Literature DB >> 17631229

Principles of antimicrobial use in older adults.

Ashley R Herring1, John C Williamson.   

Abstract

The fundamental principles of treating infectious diseases apply to elderly patients, but certain aspects of therapy such as the selection of empiric regimens and risk stratification for severe or atypical disease are influenced by comorbidities, lifestyle, and immunosenescence. Knowledge of age-related changes in pharmacokinetic parameters and potential drug-drug interactions assists the clinician in determining appropriate dosing and monitoring parameters. Based on current evidence, the recommended approach includes careful selection and aggressive dosing of initial broad-spectrum antimicrobials followed by de-escalation to appropriate agents to maximize clinical outcomes and minimize toxicity and adverse effects. Greater enrollment of the elderly in therapeutic studies is needed to detect differences in the efficacy and safety of antimicrobials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631229     DOI: 10.1016/j.cger.2007.03.009

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  4 in total

Review 1.  Challenges with Diagnosing and Managing Sepsis in Older Adults.

Authors:  Kalin M Clifford; Eliza A Dy-Boarman; Krystal K Haase; Kristen Maxvill; Steven E Pass; Carlos A Alvarez
Journal:  Expert Rev Anti Infect Ther       Date:  2016-01-14       Impact factor: 5.091

Review 2.  Elderly patients with community-acquired pneumonia: optimal treatment strategies.

Authors:  Ulrich Thiem; Hans-Jürgen Heppner; Ludger Pientka
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

Review 3.  Severe sepsis and septic shock in the elderly: An overview.

Authors:  Prashant Nasa; Deven Juneja; Omender Singh
Journal:  World J Crit Care Med       Date:  2012-02-04

4.  Trends in antibiotic prescribing in adults in Dutch general practice.

Authors:  Michiel B Haeseker; Nicole H T M Dukers-Muijrers; Christian J P A Hoebe; Cathrien A Bruggeman; Jochen W L Cals; Annelies Verbon
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.